Risk and Benefit of Oral Anticoagulants in Atrial Fibrillation

被引：0

作者：

Zotova, I. V. ^{[1
]}

Zateyshchikov, D. A. ^{[1
]}

机构：

[1] President RF, FSI Educ Sci Med Ctr, Gen Management Dept, Moscow 121356, Russia

来源：

KARDIOLOGIYA | 2011年 / 51卷 / 10期

关键词：

atrial fibrillation; indirect anticoagulants; thromboembolism; bleeding; risk stratification; CLINICAL CLASSIFICATION SCHEMES; MAJOR BLEEDING COMPLICATIONS; SOLUBLE CD40 LIGAND; WARFARIN THERAPY; STROKE RISK; VENOUS THROMBOEMBOLISM; ARTERIAL EMBOLISM; NATIONAL REGISTRY; PREDICTING STROKE; ISCHEMIC-STROKE;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Thromboembolism is the main cause of death and disability of patients with atrial fibrillation. Indirect anticoagulants are effective means of primary and secondary prevention of thromboembolic complications. However in a number of patients risk associated with therapy with indirect anticoagulants might exceed potential benefit. The principle problem requiring solution in a patient with atrial fibrillation is individual comparative assessment of risk of development of thromboembolic and hemorrhagic complications. Modern stratification scales which allow solving this problem are considered in this review.

引用

页码：81 / 91

页数：11

共 50 条

[41] Reduced risk of dementia among patients with atrial fibrillation receiving oral anticoagulants
Sposato, Luciano A.
Chen, Lin Y.
NEUROLOGY, 2018, 91 (19) : 857 - 858
[42] Diltiazem, Direct Oral Anticoagulants and Risk of Major Bleeding in Patients with Atrial Fibrillation
Chia, Jia Ee
Ang, Song Peng
Krittanawong, Chayakrit
Patel, Shreya
Mukherjee, Debabrata
CIRCULATION, 2024, 150
[43] Risk of Incident Atrial Fibrillation and Subsequent Use of Oral Anticoagulants in Patients with Dementia
Tsai, Chuan-Tsai
Chan, Yi-Hsin
Liao, Jo-Nan
Chen, Tzeng-Ji
Lip, Gregory Y. H.
Chen, Shih-Ann
Chao, Tze-Fan
THROMBOSIS AND HAEMOSTASIS, 2024, 124 (03) : 253 - 262
[44] Balancing bleeding and thrombotic risk with new oral anticoagulants in patients with atrial fibrillation
Overvad, Thure F.
Larsen, Torben B.
Albertsen, Ida E.
Rasmussen, Lars H.
Lip, Gregory Y. H.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2013, 11 (12) : 1619 - 1629
[45] Direct oral anticoagulants are associated with lower risk of dementia in patients with atrial fibrillation
Sagris, Dimitrios
Ntaios, George
Buckley, Benjamin J. R.
Harrison, Stephanie L.
Underhill, Paula
Lane, Deirdre A.
Lip, Gregory Y. H.
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 121 : 114 - 120
[46] Risk for osteoporotic fractures in patients with atrial fibrillation using different oral anticoagulants
Daehoon Kim
Pil-Sung Yang
Jung-Hoon Sung
Eunsun Jang
Hee Tae Yu
Tae-Hoon Kim
Jae-Sun Uhm
Jong-Youn Kim
Hui-Nam Pak
Moon-Hyoung Lee
Gregory Y. H. Lip
Boyoung Joung
International Journal of Arrhythmia, 22 (1)
[47] Risk and causes of hospital admission in patients with atrial fibrillation on treatment with oral anticoagulants
Pannunzio, A.
Menichelli, D.
Pignatelli, P.
Violi, F.
Brogi, T.
Lip, G. Y. H.
Pastori, D.
EUROPEAN HEART JOURNAL, 2024, 45
[48] Direct Oral Anticoagulants and Risk of Acute Kidney Injury in Patients With Atrial Fibrillation
Shin, Jung-Im
Luo, Shengyuan
Alexander, G. Caleb
Inker, Lesley A.
Coresh, Josef
Chang, Alex R.
Grams, Morgan E.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (02) : 251 - 252
[49] Oral Anticoagulants and Risk of Liver Injury in Patients With Atrial Fibrillation: A Prospective Study
Alonso, Alvaro
MacLehose, Richard F.
Chen, Lin Y.
Bengtson, Lindsay G.
Chamberlain, Alanna M.
Norby, Faye L.
Lutsey, Pamela L.
CIRCULATION, 2016, 134
[50] Bleeding Risk of Direct Oral Anticoagulants in Patients With Heart Failure And Atrial Fibrillation
Jackevicius, Cynthia A.
Lu, Lingyun
Ghaznavi, Zunera
Warner, Alberta L.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2021, 14 (02): : 155 - 168

← 1 2 3 4 5 →